Here’s what happened.
President Donald Trump suffered another major setback at the U.S. Supreme Court on Wednesday after the justices rejected his administration’s effort to restrict taxpayer-funded transgender medical treatments for federal prison inmates.
The October 21, 2026, decision prevents the administration from immediately implementing a policy that would have eliminated certain gender-transition treatments and accommodations within the federal prison system.
Despite the Supreme Court’s 6-3 conservative majority, only two justices publicly supported Trump’s emergency appeal.
The decision raises new questions about presidential authority, federal prison policies, and the limits of government spending on medical care for incarcerated individuals.
Supreme Court Delivers Setback to Trump Administration
The Supreme Court rejected an emergency request from the Justice Department to lift a lower court order blocking the administration’s proposed restrictions.
The decision allows existing medical policies to remain in place while the legal challenge continues.
The court issued a brief order without explaining its reasoning.
Conservative Justices Clarence Thomas and Samuel Alito indicated they would have granted the administration’s request.
The other seven justices did not publicly support granting emergency relief.
The outcome is particularly noteworthy because Trump appointed three members of the court’s current conservative majority: Neil Gorsuch, Brett Kavanaugh, and Amy Coney Barrett.
None of those three justices publicly joined Thomas and Alito in supporting the administration’s request.
However, the order did not disclose how each of the other justices voted.
Trump’s Plan to Restrict Federal Prison Treatments
The legal dispute began with an executive order Trump signed shortly after returning to the White House in January 2025.
The order directed federal agencies to recognize biological sex as male or female and revise certain government policies accordingly.
It also instructed federal prison officials to restrict spending on medical treatments intended to change an inmate’s physical appearance to resemble that of the opposite sex.
Under the administration’s proposed changes, the Federal Bureau of Prisons would have discontinued gender-transition surgeries and gradually ended hormone treatments for affected inmates.
The policy also addressed accommodations such as wigs, makeup, and certain clothing items.
Federal prisoners would have continued receiving mental health services and other available medical treatment.
The administration argued that prison officials should have the authority to establish appropriate treatment policies while considering medical standards and institutional security.
Opponents argued that ending previously prescribed treatments could create serious medical and psychological risks for affected prisoners.
Federal Judge Appointed by Reagan Blocks Policy
Before reaching the Supreme Court, Trump’s proposal encountered opposition in federal district court.
U.S. District Judge Royce Lamberth, who was appointed by President Ronald Reagan, blocked the administration’s restrictions in June.
Lamberth concluded that federal officials had not provided adequate justification for abruptly reversing longstanding prison medical practices.
The judge also questioned whether the government had presented sufficient evidence to support its claims about the safety and effectiveness of existing treatment policies.
His ruling focused on federal administrative law, which generally requires government agencies to provide a reasoned explanation when making significant policy changes.
A divided federal appeals court subsequently allowed the injunction to remain in place.
The Justice Department then turned to the Supreme Court, seeking permission to enforce the administration’s policy while the lawsuit continued.
Wednesday’s decision leaves the lower court injunction intact.
Taxpayer-Funded Medical Care at Center of Dispute
One of the central issues surrounding the case is how the federal government should allocate taxpayer dollars for medical services inside correctional facilities.
The Bureau of Prisons has provided hormone therapy to certain inmates diagnosed with gender dysphoria for decades.
According to court records cited by the Associated Press, approximately 600 federal inmates were receiving hormone therapy in 2025.
The Trump administration sought to change those practices, arguing that certain treatments were not justified and that federal prison officials should have greater discretion over medical policy.
Attorneys representing transgender inmates challenged that position.
They argued that abruptly discontinuing prescribed treatment could lead to serious health consequences and potentially violate constitutional protections.
The case also involves the Eighth Amendment, which prohibits cruel and unusual punishment and has been interpreted to require adequate medical care for incarcerated individuals.
The larger legal question concerns whether the administration provided sufficient justification for changing established federal prison medical policies.
Why Justices Thomas and Alito Supported Trump
Justices Clarence Thomas and Samuel Alito were the only members of the Supreme Court who publicly indicated they would have granted the administration’s emergency application.
Their position would have allowed federal officials to implement the disputed restrictions while the litigation continued.
However, neither justice issued a separate written explanation accompanying Wednesday’s order.
That means their specific reasoning in this emergency proceeding remains unclear.
The remaining justices declined to grant the requested relief without explaining their individual positions.
Importantly, the decision does not establish that seven justices believe Trump’s entire prison policy is unconstitutional.
It establishes that the administration failed to secure the emergency relief it requested.
That distinction could become important as the case progresses.
What the Supreme Court Decision Means for Trump
The Supreme Court’s action represents an immediate defeat for the administration, but it does not necessarily end the legal battle.
The justices did not issue a final ruling permanently prohibiting the federal government from changing its prison medical policies.
Instead, they declined to suspend a lower court injunction while the underlying litigation continues.
The Trump administration could still defend its position through additional legal proceedings.
Federal officials may also need to provide further evidence and legal justification for changing existing prison treatment practices.
For now, the Bureau of Prisons must continue complying with the injunction that preserves access to the disputed treatments.
The case demonstrates how federal courts can limit executive actions, even when a president’s political party holds a majority of appointments on the Supreme Court.
Another Legal Challenge for Trump’s Agenda
The dispute is part of a broader series of legal battles involving Trump’s second-term executive orders.
His administration has pursued changes to federal policies addressing biological sex, military service, official identification documents, and government-funded medical care.
Some measures have survived legal challenges, while others have faced temporary or longer-lasting restrictions.
The Supreme Court has previously allowed certain Trump administration policies involving transgender individuals to move forward.
That makes Wednesday’s ruling particularly significant.
Although Trump has repeatedly emphasized the importance of judicial appointments, the court’s conservative majority has not consistently ruled in his administration’s favor.
The latest decision also highlights the difference between winning an election, issuing an executive order, and successfully defending that order against legal challenges.
What Happens Next?
The underlying lawsuit will continue in federal court, where judges must consider the administration’s legal arguments and the evidence supporting its policy changes.
The Justice Department could ultimately prevail, but it has not secured permission to implement the restrictions at this stage.
Meanwhile, the lower court’s injunction remains in effect, preserving access to treatments covered by the existing prison policies.
For President Trump, the immediate result is another frustrating legal setback.
The Supreme Court has declined to intervene on his administration’s behalf, leaving one of his proposed federal prison reforms on hold.
Whether the White House can ultimately enforce those restrictions remains an unanswered question.
And until the litigation reaches a final resolution, the debate over federal prison medical policies, taxpayer funding, and executive authority is likely to continue.